Variable | No outcome (N = 42) | Outcome (N = 88) | All patients (N = 130) | p | |||
---|---|---|---|---|---|---|---|
Gender, male | 16 | (38.1%) | 48 | (54.5%) | 64 | (49.2%) | 0.079 |
Body mass index (kg/m2) | 21.8 | (20.0 -24.4) | 23.1 | (21.1–25.2) | 22.6 | (20.7–25.0) | 0.127 |
Body surface area (m2) | 1.7 | (1.5–1.9) | 1.7 | (1.6–1.8) | 1.7 | (1.6–1.8) | 0.811 |
Weight (kg) | 60.0 | (53.0–75.0) | 64.0 | (55.5–71.5) | 64.0 | (55.0–73.0) | 0.424 |
Height (m) | 1.7 | (1.6–1.7) | 1.7 | (1.6–1.7) | 1.7 | (1.6–1.7) | 0.657 |
Age at first CMR (years) | 18.5 | (17.0 -20.9) | 27.9 | (19.2–43.0) | 22.1 | (18.0 -36.7) | < 0.001 |
Age at TOF repair (months), N = 127 | 12.6 | (7.4–27.0) | 30.1 | (11.4–88.9) | 23.1 | (9.5–67.7) | 0.001 |
Time from repair to CMR (years), N = 127 | 17.1 | (16.2–19.1) | 23.5 | (17.4–33.2) | 19.1 | (16.8–28.5) | < 0.001 |
Follow-up time after first CMR (months) | 85.2 | (46.0 -125.6) | 125.8 | (81.3 -158.5) | 110.4 | (70.5 -149.4) | 0.002 |
Time without arrhythmias (months), N = 116 | 65.5 | (33.9–87.5) | 64.0 | (30.4 -118.6) | 64.0 | (32.3 -101.8) | 0.816 |
Type of TOF repair | 0.461 | ||||||
Transannular patch | 26 | (61.9%) | 54 | (61.4%) | 80 | (61.5%) | |
Infundibular patch | 14 | (33.3%) | 21 | (23.9%) | 35 | (26.9%) | |
Double revision of repair | 1 | (2.4%) | 5 | (5.7%) | 6 | (4.6%) | |
Other | 0 | (0.0%) | 2 | (2.3%) | 2 | (1.5%) | |
Unknown | 1 | (2.4%) | 6 | (6.8%) | 7 | (5.4%) | |
Pulmonary valve reintervention | 0.001 | ||||||
No reintervention | 31 | (73.8%) | 39 | (44.3%) | 70 | (53.8%) | |
Homograft | 7 | (16.7%) | 45 | (51.1%) | 52 | (40.0%) | |
Valvuloplasty | 1 | (2.4%) | 0 | (0.0%) | 1 | (0.8%) | |
PPVI | 3 | (7.1%) | 4 | (4.5%) | 7 | (5.4%) | |
PA procedures pre-CMR | 0.108 | ||||||
None | 34 | (81.0%) | 79 | (89.8%) | 113 | (86.9%) | |
Monolateral PA stent(s) | 6 | (14.3%) | 3 | (3.4%) | 9 | (6.9%) | |
Bilateral PA stents | 1 | (2.4%) | 1 | (1.1%) | 2 | (1.5%) | |
PTA | 1 | (2.4%) | 5 | (5.7%) | 6 | (4.6%) | |
PA procedures post-CMR pre-homograft | 0.552 | ||||||
None | 41 | (97.6%) | 81 | (92.0%) | 122 | (93.8%) | |
Monolateral PA stent(s) | 1 | (2.4%) | 3 | (3.4%) | 4 | (3.1%) | |
Bilateral PA stents | 0 | (0.0%) | 2 | (2.3%) | 2 | (1.5%) | |
PTA | 0 | (0.0%) | 2 | (2.3%) | 2 | (1.5%) | |
PA procedures post-homograft | 0.616 | ||||||
None | 42 | (100.0%) | 86 | (97.7%) | 128 | (98.5%) | |
Homograft PTA | 0 | (0.0%) | 1 | (1.1%) | 1 | (0.8%) | |
Homograft stent and PTA | 0 | (0.0%) | 1 | (1.1%) | 1 | (0.8%) |